(Q58038903)
Statements
RANTES (CCL5) uses the proteoglycan CD44 as an auxiliary receptor to mediate cellular activation signals and HIV-1 enhancement (English)
Branka Roscic-Mrkic
Marek Fischer
Christine Leemann
Amapola Manrique
Cynthia J Gordon
John P Moore
Amanda E I Proudfoot
24 April 2003